Thiazideamide derivative and use thereof

US10335417B2 · kind B2 · utility

Assignee

• INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES · CN

Inventors

• Song Li · Beijing, CN
• Junhai Xiao · Beijing, CN
• Boqun Lyu · Beijing, CN
• Hongqiang Wang · Shanghai, CN
• Wu Zhong · Beijing, CN
• Lili Wang · Beijing, CN
• Zhibing Zheng · Beijing, CN
• Yunde Xie · Beijing, CN
• Xinbo Zhou · Beijing, CN
• Xingzhou Li · Beijing, CN
• Xiaokui Wang · Beijing, CN

Key dates

• Filing date: Jun 28, 2016
• Grant date: Jul 2, 2019
• Expiry date: Jun 28, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D279/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention belongs to the technical field of medicines. In particular, the invention relates to a thiazideamide derivative compound or a pharmaceutically acceptable salt or solvate thereof, a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt or solvate thereof, a method for preparing the compound or a pharmaceutically acceptable salt or solvate thereof, and a use of the compound or a pharmaceutically acceptable salt or solvate thereof. For example, the compound or a pharmaceutically acceptable salt or solvate thereof according to the invention can be used to prevent and/or treat a neurodegenerative disease or a neuropathic disease caused by a physical trauma or a related disease.